Super painkiller: TD Hydrocodone to compete with Zohydro
DESPITE WARNINGS from lawmakers and narcs, a second company has unveiled plans for a super-painkiller with four times the amount of hydrocodone as a single Vicodin tablet.
Teva Pharmaceuticals is in the final stages of testing TD Hydrocodone, which would compete with a similar pill, Zohydro, and could hit the market by year’s end.
Both pills are extended-release capsules of pure opiate, much like OxyContin — the biggest player in America’s prescription drug problem.
William Marth of Teva told investors this week that if TD Hydrocodone gets FDA approval, it could make $500 million within a couple of years.
There is already plenty of hydrocodone on the market, but it’s paired with other non-opiates like acetaminophen.
Experts are concerned the creation of pure hydrocodone could create a new class of pill abusers and fuel illegal drug sales.
Sen. Chuck Schumer urged the FDA to slow down the “stampede” of new narcotics.
TRACY CONNOR || Thursday, January 12, 2012